Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae.

Conjugate vaccines have reduced the incidence of invasive disease caused by Haemophilus influenzae, type b (Hib), in industrialized countries and may be highly effective against Streptococcus pneumoniae. However, the serotype specificity of these vaccines has led to concern that their use may increase carriage of and disease from serotypes not included in the vaccine. Replacement has not occurred with the use of Hib vaccines but has occurred in trials of pneumococcal vaccines. Mathematical models can be used to elucidate these contrasting outcomes, predict the conditions under which serotype replacement is likely, interpret the results of conjugate vaccine trials, design trials that will better detect serotype replacement (if it occurs), and suggest factors to consider in choosing the serotype composition of vaccines.

[1]  E. Lewis,et al.  Efficacy of Heptavalent Conjugate Pneumococcal Vaccine (Wyeth Lederle) in 7,000 Infants and Children: Results of the Northern California Kaiser Permanente Efficacy Trial , 1999 .

[2]  J. Paton.  Novel pneumococcal surface proteins: role in virulence and vaccine potential. , 1998, Trends in microbiology.

[3]  A. Schuchat,et al.  Bacterial Meningitis in the United States in 1995 , 1997 .

[4]  R. Booy,et al.  Is Haemophilus influenzae finished? , 1997, The Journal of antimicrobial chemotherapy.

[5]  M. Lipsitch,et al.  Vaccination against colonizing bacteria with multiple serotypes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Breiman,et al.  Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .

[7]  D. Musher,et al.  Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  J. Butler.  Epidemiology of pneumococcal serotypes and conjugate vaccine formulations. , 1997, Microbial drug resistance.

[9]  M. Lipsitch,et al.  Virulence and transmissibility of pathogens: what is the relationship? , 1997, Trends in microbiology.

[10]  J. P. Davis,et al.  Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[11]  D. Greenberg,et al.  Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. , 1996, The Journal of infectious diseases.

[12]  R. Dagan,et al.  Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. , 1996, The Journal of infectious diseases.

[13]  S. Obaro,et al.  Carriage of pneumococci after pneumococcal vaccination , 1996, The Lancet.

[14]  M. Barbour,et al.  Conjugate vaccines and the carriage of Haemophilus influenzae type b. , 1996, Emerging infectious diseases.

[15]  M. Farley,et al.  Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  S. Kaufmann.  Concepts in vaccine development. , 1996 .

[17]  P. Ewald.  1.1. Vaccines as Evolutionary Tools: The Virulence-Antigen Strategy , 1996 .

[18]  M. Leinonen,et al.  Subtyping of common pediatric pneumococcal serotypes from invasive disease and pharyngeal carriage in Finland. , 1996, The Journal of infectious diseases.

[19]  A. M.P.H.DeborahA.AdamsTimothyM.CopelandPatsyA.HallCa,et al.  Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995. , 1996, MMWR. Morbidity and mortality weekly report.

[20]  E. Walton.  Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1993-1994. , 1996, MMWR. Morbidity and mortality weekly report.

[21]  R. Vuento,et al.  Invasive pneumococcal infections in children , 1995, The Lancet.

[22]  A. Tomasz,et al.  Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. , 1995, The Journal of infectious diseases.

[23]  R. Vuento,et al.  Increase in bacteraemic pneumococcal infections in children , 1995, The Lancet.

[24]  M. Jackson,et al.  Invasive Haemophilus influenzae type f disease. , 1995, The Pediatric infectious disease journal.

[25]  D. Crook,et al.  The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. , 1995, The Journal of infectious diseases.

[26]  Walter R. Gilks,et al.  BUGS - Bayesian inference Using Gibbs Sampling Version 0.50 , 1995 .

[27]  J. P. Dillard,et al.  Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae , 1994, Infection and immunity.

[28]  J. Bull,et al.  Short-sighted evolution and the virulence of pathogenic microorganisms. , 1994, Trends in microbiology.

[29]  Walter R. Gilks,et al.  A Language and Program for Complex Bayesian Modelling , 1994 .

[30]  P. Kaye.  Infectious diseases of humans: Dynamics and control , 1993 .

[31]  C. Broome,et al.  Rapid serologic testing with immune‐complex‐dissociated HIV p24 antigen for early detection of HIV infection in neonates , 1993 .

[32]  M. Alpers,et al.  Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children , 1993, Epidemiology and Infection.

[33]  E. Zell,et al.  Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. , 1993, JAMA.

[34]  Robert O. Walton,et al.  The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. , 1992, The Journal of infectious diseases.

[35]  C. Broome,et al.  Invasive Haemophilus influenzae disease: a population-based evaluation of the role of capsular polysaccharide serotype. Haemophilus Influenzae Study Group. , 1992, The Journal of infectious diseases.

[36]  M. Leinonen,et al.  Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. , 1991, The Journal of infectious diseases.

[37]  G Koki,et al.  Multiple colonization of the upper respiratory tract of Papua New Guinea children with Haemophilus influenzae and Streptococcus pneumoniae. , 1989, The Southeast Asian journal of tropical medicine and public health.

[38]  Moxon Er.  The carrier state: Haemophilus influenzae , 1986 .

[39]  R. Austrian,et al.  Some aspects of the pneumococcal carrier state. , 1986, The Journal of antimicrobial chemotherapy.

[40]  E. Moxon.  The carrier state: Haemophilus influenzae. , 1986, The Journal of antimicrobial chemotherapy.

[41]  J. Gruber.  Bacterial meningitis in the United States, 1978 through 1981: The national bacterial meningitis surveillance study , 1985 .

[42]  A. Sutton,et al.  Differential Complement Resistance Mediates Virulence of Haemophilus influenzae Type b , 1982, Infection and immunity.

[43]  E. Moxon,et al.  The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. , 1981, The Journal of infectious diseases.

[44]  G. Greene.  Meningitis due to Haemophilus influenzae other than type b: case report and review. , 1978, Pediatrics.

[45]  C. Sanders,et al.  Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci , 1976, Infection and immunity.

[46]  Roberts Rg,et al.  Bactericidal substance produced by Haemophilus influenzae b. , 1975 .

[47]  R. Venezia,et al.  Bactericidal substance produced by Haemophilus influenzae b. , 1975, Canadian journal of microbiology.

[48]  J. Sanford,et al.  The role of bacterial antagonism in pneumococcal colonization of the human pharynx. , 1970, The Journal of laboratory and clinical medicine.

[49]  C. Macleod,et al.  Epidemic pneumococcal pneumonia; description of the epidemic. , 1946, American journal of hygiene.